MYD88 has been found to be involved in IBD pathology [96,97] and the involvement of MYD88 in response to TNF-blocking drugs has been demonstrated in studies on rheumatoid arthritis (RA) patients [98]. This evidence concerns the gene TNF and inflammatory bowel disease.